The Etiology of Acute Leukemia

Jun 6, 2017 by in ONCOLOGY Comments Off on The Etiology of Acute Leukemia

Fig. 14.1 The two-hit model of acute leukemogenesis. This model hypothesizes that AML and ALL are the consequence of a combination of at least two broad classes of mutations. Class…

read more

Psychological Aspects of Hematological Neoplasms

Jun 6, 2017 by in ONCOLOGY Comments Off on Psychological Aspects of Hematological Neoplasms

Cognitive Evaluation of the danger versus one’s coping resources. Focus is on the perceived threat while extraneous detail environmental details are blocked out (tunnel vision). For example, a patient may…

read more

Immunobiology of Acute Leukemia

Jun 6, 2017 by in ONCOLOGY Comments Off on Immunobiology of Acute Leukemia

Earliest definition Current definition ECOG’s new definition Myeloid Myeloid Myeloid HLA-DR NEG HLA-DR NEG HLA-DRNEG CD34 HLA CD34 NEG CD11a NEG CD15 NEG CD18NEG CH15s POS CD133 NEG CD9 POS…

read more

Epidemiology of Multiple Myeloma

Jun 6, 2017 by in ONCOLOGY Comments Off on Epidemiology of Multiple Myeloma

Fig. 28.1 US myeloma mortality rates (age-adjusted, 2000 U.S. standard) by race and sex, 1953–1957 to 2003–2006 Rates specific for blacks, available since the early 1970s, are higher than rates…

read more

Diagnosis and Treatment of Multiple Myeloma

Jun 6, 2017 by in ONCOLOGY Comments Off on Diagnosis and Treatment of Multiple Myeloma

Disorder Disease definition References Monoclonal gammopathy of undetermined significance (MGUS) All 3 criteria must be met: •Serum monoclonal protein <3 g/dL •Clonal bone marrow plasma cells <10 %, and •Absence…

read more

Cytogenetics of Acute Leukemia

Jun 6, 2017 by in ONCOLOGY Comments Off on Cytogenetics of Acute Leukemia

AML with t(8;21)(q22;q22)/RUNX1-RUNX1T1 (AML1-ETO) AML with inv(16)(p13.1q22) or t(16;16)(p13.1q22)/CBFB-MYH11 APL with t(15;17)(q22;q21)/PML-RARA AML with t(9;11)(p22;q23)/MLLT3 -MLL (specify other 11q23/MLL abnormality) AML with t(6;9)(p23;q34)/DEK-NUP214(CAN)a AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)/RPN1-MECOM a AML…

read more

Non-Hodgkin Lymphoma of Childhood

Jun 6, 2017 by in ONCOLOGY Comments Off on Non-Hodgkin Lymphoma of Childhood

Syndrome Tumor Risk (%) Percent of malignancies that equal NHL Ataxia-telangiectasia Leukemia, NHL, HL, adenocarcinoma >12 41–66 Common variable ID NHL, gastric carcinoma 8–10 45–62 Severe combined ID NHL, HL,…

read more

Platelet and Granulocyte Transfusion

Jun 6, 2017 by in ONCOLOGY Comments Off on Platelet and Granulocyte Transfusion

Method Total white blood cells Platelets  ×  1011 References Mechanical apheresis Cobe spectra V5-LRS <1  ×  106 2.56–7.41 [15] Fenwal amicus <1  ×  106 2.82–7.14 [15] Cobe V7 turbo <1…

read more

Cytogenetics of Lymphomas

Jun 6, 2017 by in ONCOLOGY Comments Off on Cytogenetics of Lymphomas

Fig. 44.1 Partial karyotypes of chromosome abnormalities observed in lymphoid malignancies. The abnormal chromosomes are situated on the right side of each pair with the normal homologue on the left….

read more

History of Multiple Myeloma

Jun 6, 2017 by in ONCOLOGY Comments Off on History of Multiple Myeloma

Fig. 26.1 Plasma cells obtained at the autopsy of Thomas Alexander McBean, January 1846 (wood engravings made from drawings by Mr. Dalrymple) (Reprinted with permission from Dalrymple J. On the…

read more
Get Clinical Tree app for offline access